Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Methyl Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL44614 | 1.00 | — | — | |
| Methyl Alcohol SCHEMBL71617 | 1.00 | — | — | |
| Methyl Alcohol SCHEMBL9526155 | 1.00 | TSHR (0.75) | — | |
| Methyl Alcohol SCHEMBL9526147 | 1.00 | TSHR (0.75) | — | |
| Methyl Alcohol SCHEMBL15348234 | 1.00 | — | — | |
| Methyl Alcohol SCHEMBL44615 | 1.00 | — | — | |
| Methyl Alcohol SCHEMBL11649435 | 1.00 | — | — | |
| Methyl Alcohol SCHEMBL449756 | 1.00 | — | — | |
| Methyl Alcohol SCHEMBL321255 | 1.00 | TSHR (0.75) | — | |
| Methyl Alcohol SCHEMBL7862958 | 1.00 | TSHR (0.75) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115873146-A | Single crystal of sugammadex sodium and preparation method thereof | 广东东阳光药业有限公司 | 2023-03-31 | — | — | CN | claimed |
| EP-4314193-A1 | STABLE AIGS FILMS | Shoei Chemical Inc. (JP) | 2024-02-07 | — | — | EP | disclosed |
| CN-115873146-A | Single crystal of sugammadex sodium and preparation method thereof | 广东东阳光药业有限公司 | 2023-03-31 | — | — | CN | disclosed |
| EP-2509583-B1 | PHARMACEUTICAL COMPOSITION COMPRISING OLIGOPEPTIDES, PREFERABLY CILENGITIDE | MERCK PATENT GMBH (DE) | 2019-05-15 | — | — | EP | disclosed |
| EP-3085704-A1 | NOVEL SOLID MATERIALS OF {[(2S, 5R, 8S, 11S)-5-BENZYL-11-(3-GUANIDINO-PROPYL)-8-ISOPROPYL-7-METHYL-3,6,9,12,15-PENTAOXO-1,4,7,10,13-PENTAAZA-CYCLOPENTADEC-2-YL]-ACETIC ACID} AND METHODS FOR OBTAINING THEM | Merck Patent GmbH (DE) | 2016-10-26 | — | — | EP | disclosed |
| US-9433577-B2 | Pharmaceutical composition comprising oligopeptides | MERCK PATENT GMBH (DE) | 2016-09-06 | — | — | US | disclosed |
| CN-102652015-B | Pharmaceutical composition comprising oligopeptides, preferably cilengitide | 默克专利有限公司 | 2016-08-03 | — | — | CN | disclosed |
| EP-2432801-B1 | NOVEL SOLID MATERIALS OF {[2S, 5R,8S,11S)-5-BENZYL-11-(3-GUANIDINO-PROPYL)-8-ISOPROPYL-7-METHYL-3,6,9,12,15-PENTAOXO-1,4,7,10,13-PENTAAZA-CYCLOPENTADEC-2-YL]-ACETIC ACID} AND METHODS FOR OBTAINING THEM | MERCK PATENT GMBH (DE) | 2016-03-23 | — | — | EP | disclosed |
| CN-102428098-B | Novel solid substances of { [ (2S,5R,8S,11S) -5-benzyl-11- (3-guanidino-propyl) -8-isopropyl-7-methyl-3, 6,9,12, 15-pentaoxo-1, 4,7,10, 13-pentaaza-cyclopentadecan-2-yl ] -acetic acid } and process for obtaining them | MERCK PATENT GMBH | 2014-11-05 | — | — | CN | disclosed |
| US-8765684-B2 | Solid materials of {[(2S,5R,8S,11S)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid} and methods for obtaining them | MERCK PATENT GMBH (DE) | 2014-07-01 | — | — | US | disclosed |
| US-20140088022-A1 | Novel Solid Materials of and Methods for Obtaining Them | MERCK PATENT GMBH (DE) | 2014-03-27 | — | — | US | disclosed |
| US-8586545-B2 | Solid materials of {[(2S, 5R,8S,11S)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acid} and methods for obtaining them | MERCK PATENT GMBH (DE) | 2013-11-19 | — | — | US | disclosed |
| US-20120288539-A1 | PHARMACEUTICAL COMPOSITION COMPRISING OLIGOPEPTIDES | MERCK PATENT GMBH (DE) | 2012-11-15 | — | — | US | disclosed |
| EP-2509583-A2 | PHARMACEUTICAL COMPOSITION COMPRISING OLIGOPEPTIDES, PREFERABLY CILENGITIDE | Merck Patent GmbH (DE) | 2012-10-17 | — | — | EP | disclosed |
| EP-2432801-A2 | NOVEL SOLID MATERIALS OF {[2S, 5R,8S,11S)-5-BENZYL-11-(3-GUANIDINO-PROPYL)-8-ISOPROPYL-7-METHYL-3,6,9,12,15-PENTAOXO-1,4,7,10,13-PENTAAZA-CYCLOPENTADEC-2-YL]-ACETIC ACID} AND METHODS FOR OBTAINING THEM | Merck Patent GmbH (DE) | 2012-03-28 | — | — | EP | disclosed |
| US-20120065142-A1 | NOVEL SOLID MATERIALS OF AND METHODS FOR OBTAINING THEM | MERCK PATENT GMBH (DE) | 2012-03-15 | — | — | US | disclosed |
| WO-2011069629-A2 | PHARMACEUTICAL COMPOSITION COMPRISING OLIGOPEPTIDES | MERCK PATENT GMBH (DE) | 2011-06-16 | — | — | WO | disclosed |
| WO-2010133367-A2 | NOVEL SOLID MATERIALS OF {[2S, 5R,8S,11S)-5-BENZYL-11-(3-GUANIDINO-PROPYL)-8-ISOPROPYL-7-METHYL-3,6,9,12,15-PENTAOXO-1,4,7,10,13-PENTAAZA-CYCLOPENTADEC-2-YL]-ACETIC ACID} AND METHODS FOR OBTAINING THEM | MERCK PATENT GMBH (DE) | 2010-11-25 | — | — | WO | disclosed |